Zyn nicotine pouches have become increasingly popular among senior figures in President Donald Trump's administration, including Health and Human Services Secretary Robert F. Kennedy Jr, even as lung specialists warn that a lower risk than cigarettes is not the same as safe.

The tobacco-leaf-free oral pouches sit between the gum and lip and deliver nicotine without smoke. US regulators have now authorised a specific lower-risk marketing claim for adult smokers who switch completely.

White House Appetite Meets a Fast-Growing Brand

The small cans have circulated among Trump administration officials for months, hardly a surprise given the brand's run on the American right.

According to reports, after a lunch with tobacco executives, Mr Trump called Mr Kennedy to ask which pouches he used and expressed interest in having more such products authorised. Mr Kennedy has called nicotine pouches 'probably the safest way to consume nicotine'.

Footage from his Senate confirmation hearing on 30 January 2025, appeared to show him placing a nicotine pouch under his lip; reports later identified it as an ALP pouch rather than ZYN. Philip Morris International bought Swedish Match, maker of Zyn, for £12.0 billion ($16 billion) in 2022.

US shipments of Zyn reached 794 million cans in 2025, more than double the 2023 total. On X, commentator Mario Nawfal said the Food and Drug Administration had been speeding pouch reviews after White House pressure.

Read more

Lung Health Experts Say Zyn Nicotine Pouches Are Not Risk Free

On 30 June 2026 the FDA issued modified-risk orders covering 20 Zyn products in ten flavours at 3 milligram and 6 milligram strengths.

The authorised claim is that using Zyn instead of cigarettes puts the user at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.

The products first received marketing authorisation on 16 January 2025. The agency was explicit. 'There is no safe tobacco product, and those who do not use tobacco products should not start,' the FDA said.

Switching completely from cigarettes may cut exposure to many harmful chemicals found in smoke.

Han said nicotine pouches do not contain many of the tobacco-specific toxic compounds found in cigarette smoke, including nitrosamines linked to several cancers. She added that long-term data on the health effects of nicotine pouches are still limited.

The Centers for Disease Control and Prevention states there are no safe tobacco products, including nicotine pouches.

Youth Use and a Five-Year Regulatory Watch

The 2025 National Youth Tobacco Survey found that 1.7 per cent of US middle and high school students, about 460,000 young people, currently used nicotine pouches, a level the FDA called low and stable against 2024.

Among those users, 69.2 per cent named Zyn and 90.8 per cent used flavoured pouches. Michael Seilback of the American Lung Association said flavoured pouches were already being taken up by young people and called on the FDA to reverse the decision.

The orders last five years and require postmarket studies; the agency may withdraw them if youth use rises sharply.

The commercial prize is clear, and so is the medical caveat. Zyn nicotine pouches may reduce some harms for adult smokers who abandon cigarettes entirely.

They remain addictive nicotine products that lung specialists say nobody who does not already use tobacco should start.

Read more